Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study
To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Hea...
Gespeichert in:
Veröffentlicht in: | Scandinavian journal of primary health care 2022-03, Vol.40 (1), p.39-47 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 47 |
---|---|
container_issue | 1 |
container_start_page | 39 |
container_title | Scandinavian journal of primary health care |
container_volume | 40 |
creator | Mikkola, Ilona Morgan, Simon Winell, Klas Jokelainen, Jari Frittitta, Lucia Heikkala, Eveliina Hagnäs, Maria |
description | To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D).
Primary care T2D outpatients from the Rovaniemi Health Centre.
The municipal health centre, Rovaniemi, Finland.
A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'.
Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services.
A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p |
doi_str_mv | 10.1080/02813432.2022.2036458 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_02813432_2022_2036458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4ed2e2ff18b44beb81996c80f80404f5</doaj_id><sourcerecordid>2942013612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEosPAI4AssWHBFN-S2CwQVcWlUiU2sLYc53jqUcYOttNq3pZHwZlLoSzY-Pqd_5xj_1X1kuBzggV-h6kgjDN6TjGdB9bwWjyqFqTGdNW2lD-uFjOzmqGz6llKG4yJwJI9rc5YTbhoGrqofl2kFIzT2QWPgkUjxBS8HlyCHhkdAY2D9gnduXyDtsG7HKLza6R9uQ4-xzDMYWZw3hld1lM2YQvpLRojJBPdeFLeQl-I_W4OnrIrSf7kjW6r4-6QMkG8dQYSch6NBQGfjxXk3QiIot7pDjKk90UKhW7m90qlgAh6WN2FOPQo5anfPa-eWD0keHGcl9WPz5--X35dXX_7cnV5cb0ydUPzygiMRStr3hNphSG2M30jjdSYEQvatkIIbjsGLe5AdMCalrd9XQ5ozzhlbFldHXT7oDfq2I4K2qn9QYhrpWN2ZgDFoadArSWi47yDThApm1KAFZhjbuui9eGgNU5deTZT-o96eCD68Ma7G7UOt0piiZmUReDNUSCGnxOkrLYuGRjKV0KYkqINFVQKVuhl9fofdBOmWF6yUJJTTFhDaKHqA2ViSCmCvS-GYDX7UZ38qGY_qqMfS9yrvzu5jzoZsAAfD4DzNsSt3v-cyno3hGij9sYlxf6f4zfVL_ZE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2942013612</pqid></control><display><type>article</type><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><source>Taylor & Francis Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</creator><creatorcontrib>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</creatorcontrib><description>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D).
Primary care T2D outpatients from the Rovaniemi Health Centre.
The municipal health centre, Rovaniemi, Finland.
A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'.
Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services.
A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p < 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p < 0.001).
Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D.
Key Points
Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with
more frequent monitoring for clinical outcomes,
more frequent prescription of cardiovascular and antihyperglycemic medication and
more frequent utilisation of planned diabetes consultations when compared to usual care.</description><identifier>ISSN: 0281-3432</identifier><identifier>EISSN: 1502-7724</identifier><identifier>DOI: 10.1080/02813432.2022.2036458</identifier><identifier>PMID: 35148662</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Aged ; Blood pressure ; care plan ; Care plans ; Cholesterol ; Clinical outcomes ; Cross-Sectional Studies ; Customization ; Density ; Diabetes ; Diabetes Mellitus, Type 2 - therapy ; Drugs ; general practice services ; Glycated Hemoglobin A - analysis ; Goal achievement ; Health facilities ; Hemoglobin ; Humans ; Hypoglycemic Agents - therapeutic use ; Original ; Outpatients ; patient-centric care ; Patients ; Prescriptions ; Primary care ; Primary Health Care ; Retrospective Studies ; type 2 diabetes ; Type 2 diabetes mellitus</subject><ispartof>Scandinavian journal of primary health care, 2022-03, Vol.40 (1), p.39-47</ispartof><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</citedby><cites>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090399/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090399/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2100,12844,27500,27922,27923,30997,53789,53791,59141,59142</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35148662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikkola, Ilona</creatorcontrib><creatorcontrib>Morgan, Simon</creatorcontrib><creatorcontrib>Winell, Klas</creatorcontrib><creatorcontrib>Jokelainen, Jari</creatorcontrib><creatorcontrib>Frittitta, Lucia</creatorcontrib><creatorcontrib>Heikkala, Eveliina</creatorcontrib><creatorcontrib>Hagnäs, Maria</creatorcontrib><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><title>Scandinavian journal of primary health care</title><addtitle>Scand J Prim Health Care</addtitle><description>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D).
Primary care T2D outpatients from the Rovaniemi Health Centre.
The municipal health centre, Rovaniemi, Finland.
A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'.
Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services.
A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p < 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p < 0.001).
Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D.
Key Points
Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with
more frequent monitoring for clinical outcomes,
more frequent prescription of cardiovascular and antihyperglycemic medication and
more frequent utilisation of planned diabetes consultations when compared to usual care.</description><subject>Aged</subject><subject>Blood pressure</subject><subject>care plan</subject><subject>Care plans</subject><subject>Cholesterol</subject><subject>Clinical outcomes</subject><subject>Cross-Sectional Studies</subject><subject>Customization</subject><subject>Density</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Drugs</subject><subject>general practice services</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Goal achievement</subject><subject>Health facilities</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Original</subject><subject>Outpatients</subject><subject>patient-centric care</subject><subject>Patients</subject><subject>Prescriptions</subject><subject>Primary care</subject><subject>Primary Health Care</subject><subject>Retrospective Studies</subject><subject>type 2 diabetes</subject><subject>Type 2 diabetes mellitus</subject><issn>0281-3432</issn><issn>1502-7724</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEosPAI4AssWHBFN-S2CwQVcWlUiU2sLYc53jqUcYOttNq3pZHwZlLoSzY-Pqd_5xj_1X1kuBzggV-h6kgjDN6TjGdB9bwWjyqFqTGdNW2lD-uFjOzmqGz6llKG4yJwJI9rc5YTbhoGrqofl2kFIzT2QWPgkUjxBS8HlyCHhkdAY2D9gnduXyDtsG7HKLza6R9uQ4-xzDMYWZw3hld1lM2YQvpLRojJBPdeFLeQl-I_W4OnrIrSf7kjW6r4-6QMkG8dQYSch6NBQGfjxXk3QiIot7pDjKk90UKhW7m90qlgAh6WN2FOPQo5anfPa-eWD0keHGcl9WPz5--X35dXX_7cnV5cb0ydUPzygiMRStr3hNphSG2M30jjdSYEQvatkIIbjsGLe5AdMCalrd9XQ5ozzhlbFldHXT7oDfq2I4K2qn9QYhrpWN2ZgDFoadArSWi47yDThApm1KAFZhjbuui9eGgNU5deTZT-o96eCD68Ma7G7UOt0piiZmUReDNUSCGnxOkrLYuGRjKV0KYkqINFVQKVuhl9fofdBOmWF6yUJJTTFhDaKHqA2ViSCmCvS-GYDX7UZ38qGY_qqMfS9yrvzu5jzoZsAAfD4DzNsSt3v-cyno3hGij9sYlxf6f4zfVL_ZE</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Mikkola, Ilona</creator><creator>Morgan, Simon</creator><creator>Winell, Klas</creator><creator>Jokelainen, Jari</creator><creator>Frittitta, Lucia</creator><creator>Heikkala, Eveliina</creator><creator>Hagnäs, Maria</creator><general>Taylor & Francis</general><general>Taylor & Francis LLC</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QJ</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202203</creationdate><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><author>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Blood pressure</topic><topic>care plan</topic><topic>Care plans</topic><topic>Cholesterol</topic><topic>Clinical outcomes</topic><topic>Cross-Sectional Studies</topic><topic>Customization</topic><topic>Density</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Drugs</topic><topic>general practice services</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Goal achievement</topic><topic>Health facilities</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Original</topic><topic>Outpatients</topic><topic>patient-centric care</topic><topic>Patients</topic><topic>Prescriptions</topic><topic>Primary care</topic><topic>Primary Health Care</topic><topic>Retrospective Studies</topic><topic>type 2 diabetes</topic><topic>Type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikkola, Ilona</creatorcontrib><creatorcontrib>Morgan, Simon</creatorcontrib><creatorcontrib>Winell, Klas</creatorcontrib><creatorcontrib>Jokelainen, Jari</creatorcontrib><creatorcontrib>Frittitta, Lucia</creatorcontrib><creatorcontrib>Heikkala, Eveliina</creatorcontrib><creatorcontrib>Hagnäs, Maria</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scandinavian journal of primary health care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikkola, Ilona</au><au>Morgan, Simon</au><au>Winell, Klas</au><au>Jokelainen, Jari</au><au>Frittitta, Lucia</au><au>Heikkala, Eveliina</au><au>Hagnäs, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</atitle><jtitle>Scandinavian journal of primary health care</jtitle><addtitle>Scand J Prim Health Care</addtitle><date>2022-03</date><risdate>2022</risdate><volume>40</volume><issue>1</issue><spage>39</spage><epage>47</epage><pages>39-47</pages><issn>0281-3432</issn><eissn>1502-7724</eissn><abstract>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D).
Primary care T2D outpatients from the Rovaniemi Health Centre.
The municipal health centre, Rovaniemi, Finland.
A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'.
Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services.
A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p < 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p < 0.001).
Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D.
Key Points
Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with
more frequent monitoring for clinical outcomes,
more frequent prescription of cardiovascular and antihyperglycemic medication and
more frequent utilisation of planned diabetes consultations when compared to usual care.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>35148662</pmid><doi>10.1080/02813432.2022.2036458</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0281-3432 |
ispartof | Scandinavian journal of primary health care, 2022-03, Vol.40 (1), p.39-47 |
issn | 0281-3432 1502-7724 |
language | eng |
recordid | cdi_crossref_primary_10_1080_02813432_2022_2036458 |
source | Taylor & Francis Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Applied Social Sciences Index & Abstracts (ASSIA); EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Aged Blood pressure care plan Care plans Cholesterol Clinical outcomes Cross-Sectional Studies Customization Density Diabetes Diabetes Mellitus, Type 2 - therapy Drugs general practice services Glycated Hemoglobin A - analysis Goal achievement Health facilities Hemoglobin Humans Hypoglycemic Agents - therapeutic use Original Outpatients patient-centric care Patients Prescriptions Primary care Primary Health Care Retrospective Studies type 2 diabetes Type 2 diabetes mellitus |
title | Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20personalised%20care%20plans%20with%20monitoring%20and%20control%20of%20clinical%20outcomes,%20prescription%20of%20medication%20and%20utilisation%20of%20primary%20care%20services%20in%20patients%20with%20type%202%20diabetes:%20an%20observational%20real-world%20study&rft.jtitle=Scandinavian%20journal%20of%20primary%20health%20care&rft.au=Mikkola,%20Ilona&rft.date=2022-03&rft.volume=40&rft.issue=1&rft.spage=39&rft.epage=47&rft.pages=39-47&rft.issn=0281-3432&rft.eissn=1502-7724&rft_id=info:doi/10.1080/02813432.2022.2036458&rft_dat=%3Cproquest_cross%3E2942013612%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2942013612&rft_id=info:pmid/35148662&rft_doaj_id=oai_doaj_org_article_4ed2e2ff18b44beb81996c80f80404f5&rfr_iscdi=true |